ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling-Reference-Cited by-同舟云学术

ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling

Published:2019-01-07 Issue:3 Volume:58 Page:175-185
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Christgen Matthias¹,Bartels Stephan¹,Radner Martin¹,Raap Mieke¹,Rieger Luisa¹,Christgen Henriette¹,Gluz Oleg²³⁴,Nitz Ulrike²³,Harbeck Nadia²⁵,Lehmann Ulrich¹,Kreipe Hans¹

Affiliation:

1. Institute of Pathology; Hannover Medical School; Hannover Germany

2. West German Study Group; Moenchengladbach Germany

3. Breast Center Niederrhein; Evangelic Bethesda Hospital; Moenchengladbach Germany

4. University Clinics Cologne; Cologne, Germany

5. Breast Center, Department of Obstetrics and Gynecology; University of Munich (LMU); Munich Germany

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.22716/fullpdf

Reference35 articles.

1. Assessing HER2 amplification in breast cancer: findings from the Australian in situ hybridization program;Bilous;Breast Cancer Res Treat,2012

2. Quality assessment of HER2 testing by monitoring of positivity rates;Choritz;Virchows Arch,2011

3. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update;Wolff;J Clin Oncol,2013

4. Activating HER2 mutations in HER2 gene amplification negative breast cancer;Bose;Cancer Discov,2013

5. Comprehensive molecular portraits of human breast tumours;Koboldt;Nature,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity;Virchows Archiv;2024-08-28

2. Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer;Molecular Oncology;2024-01-29

3. ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features;The Journal of Pathology: Clinical Research;2024-01-21

4. Molecular pathology in breast disease: diagnostic, prognostic, and therapeutic tools;Virchows Archiv;2023-11-28

5. Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights;Cancers;2023-11-20